Interaction of zinc with antidepressants in the forced swimming test in mice

Polish Journal of Pharmacology

Volumn 54, Issue 6, 2002, Pages 681-685

  Szewczyk, Bernadeta ^a   Brański, Piotr ^a   Wierońska, Joanna M ^a   Pałucha, Agnieszka ^a   Pilc, Andrzej ^a,b   Nowak, Gabriel ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antidepressants; Forced swimming test; Locomotor activity; NMDA receptor; Zinc

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; GLUTAMIC ACID; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FORCED SWIMMING TEST; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; RECEPTOR BLOCKING; SHORT SURVEY;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; IMMOBILIZATION; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING; ZINC;

EID: 0036965660     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (25)

1. Frederickson Ch.J., Won Suh S., Silva D., Frederickson C.J., Thompson R.B.: Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr., 2000, 130, 1471S-1483S.
2. Harrison N.L., Gibbsons S.J.: Zn: an endogenous modulator of ligand- and voltage-gated ion channels, Neuropharmacology, 1994, 33, 935-952.
3. Kroczka B., Brański P., Pałucha A., Pilc A., Nowak G.: Antidepressant-like properties of zinc in rodent forced swim test. Brain Res. Bull., 2001, 55, 297-300.
4. Kroczka B., Ziȩba A., Dudek D., Pilc A., Nowak G.: Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol. J. Pharmacol., 2000, 52, 403-406.
5. Maes M., D'Haese P.C., Scharpe S., D'Hondt P.D., Cosyns P., De Broe M.E.: Hypozincemia in depression. J. Affect. Disorders, 1994, 31, 135-140.
6. Maj J., Rogóz Z., Skuza G., Sowińska H.: Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur. J. Neuropsychopharmacol., 1992, 2, 37-41.
7. McLoughlin I.J., Hodge J.S.: Zinc in depressive disorder. Acta Psychiat. Scand., 1990, 82, 451-453.
8. Nowak G., Kubera M., Maes M.: Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression. Acta Neuropsychiat., 2000, 12, 49-53.
9. Nowak G., Legutko B., Skolnick P., Popik P.: Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. Eur. J. Pharmacol., 1998, 342, 367-370.
10. Nowak G., Li Y., Paul I. A.: Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol., 1996, 295, 75-85.
11. Nowak G., Schlegel-Zawadzka M.: Alterations in serum and brain trace element levels after antidepressant treatment. Part I. Zinc. Biol. Tr. Elem. Res., 1999, 67, 85-92.
12. Nowak G., Trullas R., Layer R.T., Skolnick P., Paul I.A.: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther., 1993, 265, 1380-1386.
13. Nowak G., Ziȩba A., Dudek D., Krośniak M., Szymaczek M., Schlegel-Zawadzka M.: Serum trace elements in animal models and human depression. Part I. Zinc. Hum. Psychopharmacol. Clin. Exp., 1999, 14, 83-86.
14. Paul I.A., Layer R.T., Skolnick P., Nowak G.: Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol.-Molec. Pharm., 1993, 247, 305-311.
15. Paul I.A., Nowak G., Layer R.T., Popik P., Skolnick P.: Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther., 1994, 269, 95-102.
16. Popik P., Wróbel M., Nowak G.: Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology, 2000, 39, 2278-2287.
17. Porsolt R.D., Bertin A., Jalfre M.: Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Thér. 1977, 229, 327-336.
18. Schlegel-Zawadzka M., Ziȩba A., Dudek D., Krośniak M., Szymaczek M., Nowak G.: Effect of depression and of antidepressant therapy on serum zinc levels - a preliminary clinical study. In: Trace Elements in Man and Animals 10, Kluwer Academic Plenum Press, 2000, 607-610.
19. Skolnick P.: Antidepressants for the new millennium. Eur. J. Pharmacol., 1999, 375, 31-40.
20. Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R.: Adaptation of N-methyl-D-aspartate receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry, 1996, 29, 23-26.
21. Skolnick P., Legutko B., Li X., Bymaster F. P.: Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol. Res., 2001, 43, 411-422.
22. Szewczyk B., Kata R., Nowak G.: Rise in zinc affinity for the NMDA receptor evoked by chronic imipramine is species specific. Pol. J. Pharmacol., 2001, 53, 641-645.
23. Takeda A.: Movement of zinc and its functional significance in the brain. Brain. Res. Bull., 2000, 34, 137-148.
24. Trullas R., Skolnick P.: Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol., 1990, 185, 1-10.
25. Vaidya V.A., Siuciak J.A., Du F., Duman R.S.: Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizure. Neuroscience, 1999, 89, 157-166.